ADTX

Aditxt, Inc. ADTX

ADTX
Aditxt, Inc. HESG
Health Sciences Group, Inc. EHOS
Ehouse Global, Inc. ONCO
Onconetix, Inc. VCNX
Vaccinex, Inc. STMM
Stemcell Holdings, Inc. ENVB
Enveric Biosciences, Inc. AGNPF
Algernon Pharmaceuticals Inc. BITRF
Biotron Limited ASBP
Aspire Biopharma Holdings, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ADTX HESG EHOS ONCO VCNX STMM ENVB AGNPF BITRF ASBP
6M -82.27 % 900.00 % 900.00 % -30.75 % -21.43 % 0.00 % -47.01 % -20.63 % -44.44 % -45.80 %
YTD -98.95 % 900.00 % 9 900.00 % -93.37 % -42.11 % 0.00 % -88.68 % 7.99 % -85.03 % -97.22 %
1Y -99.81 % 900.00 % 9 900.00 % -99.30 % -74.65 % 0.00 % -89.28 % -3.29 % -89.73 % -97.22 %
3Y -100.00 % 0.00 % 0.00 % -99.92 % -99.51 % 0.00 % -98.72 % -92.00 % -94.92 % -97.22 %
5Y -100.00 % 0.00 % 999 900.00 % -100.00 % -99.87 % 0.00 % -99.98 % -99.12 % -97.89 % -97.22 %
10Y -100.00 % 0.00 % -99.00 % -100.00 % -99.98 % 0.00 % -100.00 % -99.71 % -97.00 % -97.22 %
From the beginning -100.00 % -99.99 % 233.33 % -100.00 % -99.98 % 0.00 % -100.00 % -99.71 % -99.03 % -97.22 %

Dividend

Enveric Biosciences, Inc.